Cabergoline
Cabergoline is a dopamine agonist used to lower prolactin in selected endocrine conditions. Symptoms, prolactin levels and tumour imaging may guide treatment and follow-up. Listed uses include hyperprolactinaemia and prolactinoma.
Key points
- Cabergoline can restore fertility, so pregnancy plans and contraception may need early review.
- Low blood pressure, heart-valve or fibrotic disease, sudden sleepiness and impulse-control changes can affect safety.
- Severe headache with visual change, chest pain, fainting or new breathlessness needs urgent assessment.
Listings are for comparison only. Suitability and supply depend on clinician and pharmacy checks, stock, destination rules and prescription requirements.
How it works
Cabergoline activates dopamine D2 receptors in the pituitary gland, reducing prolactin release.
Important safety checks
Pregnancy, blood pressure, heart-valve or fibrotic disease, severe mental-health symptoms and interacting medicines require review. Monitoring may include prolactin levels, imaging and heart assessment. Report compulsive gambling, spending, eating or sexual behaviour.
When to seek urgent care
Seek urgent help for a sudden severe headache, new visual loss, chest pain, fainting, coughing blood, new or worsening breathlessness, severe confusion or hallucinations that create danger.